fluconazole has been researched along with Chronic Disease in 55 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"To determine the efficacy and safety of fluconazole as treatment for coccidioidomycosis." | 9.08 | Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. ( Catanzaro, A; Chapman, SW; Cloud, G; Fierer, J; Galgiani, JN; Levine, BE; Sharkey-Mathis, PK; Stevens, DA, 1995) |
"To study the efficacy of fluconazole against chronic disseminated candidiasis (hepatosplenic candidiasis) in patients with leukemia in whom amphotericin B treatment had failed." | 9.07 | Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. ( Anaissie, E; Barnett, K; Bodey, GP; Bow, E; David, C; Defelice, R; Downs, N; File, T; Kantarjian, H; Karam, G, 1991) |
" Chronic and recurrent vulvovaginitis, however, does not respond to this standard experimental therapy; therefore, the study presented in this article investigated the effect of common antifungal drugs (amphotericin B [AMB], fluconazole [FLU], and itraconazole [ITC]), in combination with 2-phenylethanol, on the Candida species isolated from cases of chronic and recurrent vulvovaginitis, thereby allowing the recommendation of a more appropriate treatment option." | 7.88 | Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis. ( Ashrafi-Khozani, M; Falahati, M; Farahyar, S; Heidarie-Kohan, F; Majdabadi, N; Mohammadnejad, S; Rahimi-Moghaddam, P; Razavi, T, 2018) |
"To investigate the potential use of fluconazole for prevention and treatment of disseminated candidiasis in granulocytopenic patients, its in vivo antifungal activity was studied in three models of disseminated candidiasis in persistently granulocytopenic rabbits: acute, subacute, and chronic disseminated candidiasis." | 7.68 | Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. ( Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ, 1990) |
"To determine the efficacy and safety of fluconazole as treatment for coccidioidomycosis." | 5.08 | Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. ( Catanzaro, A; Chapman, SW; Cloud, G; Fierer, J; Galgiani, JN; Levine, BE; Sharkey-Mathis, PK; Stevens, DA, 1995) |
"To study the efficacy of fluconazole against chronic disseminated candidiasis (hepatosplenic candidiasis) in patients with leukemia in whom amphotericin B treatment had failed." | 5.07 | Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. ( Anaissie, E; Barnett, K; Bodey, GP; Bow, E; David, C; Defelice, R; Downs, N; File, T; Kantarjian, H; Karam, G, 1991) |
" Chronic and recurrent vulvovaginitis, however, does not respond to this standard experimental therapy; therefore, the study presented in this article investigated the effect of common antifungal drugs (amphotericin B [AMB], fluconazole [FLU], and itraconazole [ITC]), in combination with 2-phenylethanol, on the Candida species isolated from cases of chronic and recurrent vulvovaginitis, thereby allowing the recommendation of a more appropriate treatment option." | 3.88 | Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis. ( Ashrafi-Khozani, M; Falahati, M; Farahyar, S; Heidarie-Kohan, F; Majdabadi, N; Mohammadnejad, S; Rahimi-Moghaddam, P; Razavi, T, 2018) |
"Models of acute and chronic candidiasis were developed in Fischer 344 rats to evaluate the therapeutic efficacy of recombinant human macrophage colony-stimulating factor (rhM-CSF) alone and in combination with the antifungal agent fluconazole." | 3.69 | Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. ( Ando, D; Aukerman, SL; Fidler, JM; Vitt, CR; Zimmerman, RJ, 1994) |
" Fluconazole, used here for the only time of which we are aware to treat cryptococcal endophthalmitis, produced successful conversion to culture negativity and resolution of the uveitis." | 3.69 | An unusual case of cryptococcal endophthalmitis. ( Custis, PH; de Juan, E; Haller, JA, 1995) |
"To investigate the potential use of fluconazole for prevention and treatment of disseminated candidiasis in granulocytopenic patients, its in vivo antifungal activity was studied in three models of disseminated candidiasis in persistently granulocytopenic rabbits: acute, subacute, and chronic disseminated candidiasis." | 3.68 | Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. ( Aoki, S; Bacher, J; Lee, J; Mechinaud, F; Pizzo, PA; Rubin, M; Walsh, TJ, 1990) |
" In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
" The LNG-IUS was removed in six patients and of these, two experienced clinical improvement with lower fluconazole dosage requirements and three experienced complete resolution of symptoms." | 1.48 | Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device. ( Fischer, G; Nguyen, Y, 2018) |
"Fluconazole treatment at a dose of 50-100 mg daily achieved a significant observable and improvement in the QoL of 96% of patients with CVVC within 12 weeks of treatment." | 1.46 | Quality of life in patients with chronic vulvovaginal candidiasis: A before and after study on the impact of oral fluconazole therapy. ( Fischer, G; Lee, A; Nguyen, Y, 2017) |
"Prior use of fluconazole, severe respiratory failure and hospitalization time are associated with IPA in patients with chronic pneumopathies with respiratory isolation of Aspergillus spp." | 1.38 | [Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. ( Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J, 2012) |
"albicans (n = 19) isolates from nine APECED patients reported with decreased susceptibility to fluconazole isolated up to 9 years apart were included." | 1.36 | Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. ( Bowyer, P; Rautemaa, R; Richardson, M; Sanglard, D; Saxen, H; Siikala, E, 2010) |
"Infarctions though rare in cryptococcal meningitis should be considered in patients with chronic meningitis with vasculitis." | 1.30 | Midbrain infarction: a rare presentation of cryptococcal meningitis. ( Ayagiri, A; Bansal, R; Kalita, J; Misra, UK, 1999) |
"The drug proved effective and safe." | 1.29 | [Use of Diflucan in the treatment of chronic and recurrent candidosis with involvement of the esophagus]. ( Antonov, VV; Barantsevich, EP; Nizamutdinova, AS, 1996) |
"Treatment with amphotericin B, flucytosine and high doses of fluconazole was followed by clinical improvement, although CSF pleocytosis remained." | 1.28 | First report of chronic meningitis caused by Trichosporon beigelii. ( Boogaerts, M; Marcelis, L; Surmont, I; Verbist, L; Vergauwen, B; Verhoef, G, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 21 (38.18) | 18.2507 |
2000's | 18 (32.73) | 29.6817 |
2010's | 15 (27.27) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Rewak-Soroczynska, J | 1 |
Sobierajska, P | 1 |
Targonska, S | 1 |
Piecuch, A | 1 |
Grosman, L | 1 |
Rachuna, J | 1 |
Wasik, S | 1 |
Arabski, M | 1 |
Ogorek, R | 1 |
Wiglusz, RJ | 1 |
Majdabadi, N | 1 |
Falahati, M | 1 |
Heidarie-Kohan, F | 1 |
Farahyar, S | 1 |
Rahimi-Moghaddam, P | 1 |
Ashrafi-Khozani, M | 1 |
Razavi, T | 1 |
Mohammadnejad, S | 1 |
Bartenstein, D | 1 |
Chung, HJ | 1 |
Hussain, S | 1 |
Head, K | 1 |
Sharp, S | 1 |
Chong, LY | 1 |
Hopkins, C | 1 |
Philpott, C | 1 |
Demers, EG | 1 |
Biermann, AR | 1 |
Masonjones, S | 1 |
Crocker, AW | 1 |
Ashare, A | 1 |
Stajich, JE | 1 |
Hogan, DA | 1 |
Gianni, C | 1 |
Imadojemu, S | 1 |
Rubin, A | 1 |
Nguyen, Y | 3 |
Lee, A | 2 |
Fischer, G | 3 |
Rammaert, B | 1 |
Candon, S | 1 |
Maunoury, C | 1 |
Bougnoux, ME | 1 |
Jouvion, G | 1 |
Braun, T | 1 |
Correas, JM | 1 |
Lortholary, O | 1 |
Pereira, GH | 1 |
Pádua, SS | 1 |
Park, MV | 1 |
Muller, RP | 1 |
Passos, RM | 1 |
Menezes, Y | 1 |
Addidle, M | 1 |
Pynn, J | 1 |
Skellern, P | 1 |
Kasuga, T | 1 |
Grimwade, K | 1 |
Siikala, E | 1 |
Rautemaa, R | 1 |
Richardson, M | 1 |
Saxen, H | 1 |
Bowyer, P | 1 |
Sanglard, D | 1 |
Patel, SM | 1 |
Patel, SS | 1 |
Myers, R | 1 |
Castón, JJ | 1 |
Linares, MJ | 1 |
Rivero, A | 1 |
Casal, M | 1 |
Torre-Cisneros, J | 1 |
Ratip, S | 1 |
Odabaşi, Z | 1 |
Karti, S | 1 |
Cetiner, M | 1 |
Yeğen, C | 1 |
Cerikcioğlu, N | 1 |
Bayik, M | 1 |
Korten, V | 1 |
Sandhu, K | 1 |
Jain, R | 1 |
Kaur, I | 1 |
Kumar, B | 1 |
Sungkanuparph, S | 1 |
Tanphaichitra, D | 1 |
Pracharktam, R | 1 |
Tsuchiyama, T | 1 |
Naitoh, H | 1 |
Kouzuma, K | 1 |
Motoyama, H | 1 |
Kinuwaki, E | 1 |
Eschenbach, DA | 1 |
Sabbatani, S | 1 |
Manfredi, R | 1 |
Pavoni, M | 1 |
Consales, A | 1 |
Chiodo, F | 1 |
Jen, A | 1 |
Kacker, A | 1 |
Huang, C | 1 |
Anand, V | 1 |
Masood, A | 1 |
Sallah, S | 1 |
Borisov, I | 1 |
Kolarov, G | 1 |
Bobcheva, S | 1 |
Ivanova, A | 1 |
Quante, G | 1 |
Wittekindt, C | 1 |
Beutner, D | 1 |
Preuss, SF | 1 |
Damm, M | 1 |
Hüttenbrink, KB | 1 |
Goldman, DL | 1 |
Davis, J | 1 |
Bommarito, F | 1 |
Shao, X | 1 |
Casadevall, A | 1 |
Brown, RS | 1 |
Bailey, J | 1 |
Winfree, WJ | 1 |
Harden, S | 1 |
Blignaut, E | 1 |
Botes, ME | 1 |
Nieman, HL | 1 |
Badreshia, S | 1 |
Klepeiss, S | 1 |
Ioffreda, M | 1 |
Miller, J | 1 |
Adams, DR | 1 |
Mackley, C | 1 |
Rodríguez, VE | 1 |
Freuler, CB | 1 |
Ezcurra, C | 1 |
Durlach, RA | 1 |
Nyirjesy, P | 1 |
Seeney, SM | 1 |
Grody, MH | 1 |
Jordan, CA | 1 |
Buckley, HR | 1 |
Catanzaro, A | 1 |
Galgiani, JN | 1 |
Levine, BE | 1 |
Sharkey-Mathis, PK | 1 |
Fierer, J | 1 |
Stevens, DA | 1 |
Chapman, SW | 1 |
Cloud, G | 1 |
Vitt, CR | 1 |
Fidler, JM | 1 |
Ando, D | 1 |
Zimmerman, RJ | 1 |
Aukerman, SL | 1 |
Borne, MJ | 1 |
Elliott, JH | 1 |
O'Day, DM | 1 |
Custis, PH | 1 |
Haller, JA | 1 |
de Juan, E | 1 |
Pereiro, M | 2 |
García García, A | 1 |
Toribio, J | 1 |
Kunzelmann, V | 1 |
Tietz, HJ | 2 |
Rossner, D | 1 |
Czaika, V | 2 |
Hopp, M | 1 |
Schmalreck, A | 2 |
Sterry, W | 2 |
Kawayama, T | 1 |
Sawa, A | 1 |
Sueyasu, Y | 1 |
Arikawa, K | 1 |
Shiraishi, T | 1 |
Ichikawa, Y | 1 |
Oizumi, K | 1 |
Barantsevich, EP | 1 |
Antonov, VV | 1 |
Nizamutdinova, AS | 1 |
McDonald, JA | 1 |
Saulsbury, FT | 1 |
Hirano, K | 1 |
Saitoh, T | 1 |
Kadono, K | 1 |
Oose, H | 1 |
Watanabe, S | 1 |
Hasegawa, S | 1 |
Kalita, J | 1 |
Bansal, R | 1 |
Ayagiri, A | 1 |
Misra, UK | 1 |
Mariushi, WM | 1 |
Arruda, WO | 1 |
Tsubouchi, MH | 1 |
Ramina, R | 1 |
Zabkowski, T | 1 |
Peterek, J | 1 |
Stawarz, B | 1 |
Bejm, J | 1 |
Sulik, M | 1 |
Bańcer, M | 1 |
Arsura, EL | 1 |
Kilgore, WB | 1 |
Gangadharan, VP | 1 |
Sasidharan, K | 1 |
Preetha, S | 1 |
Chithrathara, K | 1 |
Schultze, W | 1 |
Blade, J | 1 |
Lopez-Guillermo, A | 1 |
Rozman, C | 1 |
Grañena, A | 1 |
Bruguera, M | 1 |
Bordas, J | 1 |
Cervantes, F | 1 |
Carreras, E | 1 |
Sierra, J | 1 |
Montserrat, E | 1 |
Lewis, MA | 1 |
Samaranyake, LP | 1 |
Lamey, PJ | 1 |
Just-Nübling, G | 1 |
Gentschew, G | 1 |
Meissner, K | 1 |
Odewald, J | 1 |
Staszewski, S | 1 |
Helm, EB | 1 |
Stille, W | 1 |
Anaissie, E | 1 |
Bodey, GP | 1 |
Kantarjian, H | 1 |
David, C | 1 |
Barnett, K | 1 |
Bow, E | 1 |
Defelice, R | 1 |
Downs, N | 1 |
File, T | 1 |
Karam, G | 1 |
Walsh, TJ | 1 |
Aoki, S | 1 |
Mechinaud, F | 1 |
Bacher, J | 1 |
Lee, J | 1 |
Rubin, M | 1 |
Pizzo, PA | 1 |
Surmont, I | 1 |
Vergauwen, B | 1 |
Marcelis, L | 1 |
Verbist, L | 1 |
Verhoef, G | 1 |
Boogaerts, M | 1 |
5 reviews available for fluconazole and Chronic Disease
Article | Year |
---|---|
Topical and systemic antifungal therapy for chronic rhinosinusitis.
Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Chronic Disease; Fluconazole; Hum | 2018 |
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Chronic Disease; Fluconazole; Humans; Leukemia, Myel | 2005 |
[Acute cholecystitis and biliary tract infections due to Candida].
Topics: Aged, 80 and over; Antifungal Agents; Biliary Tract Diseases; Bronchitis; Candidiasis; Cholecystecto | 2007 |
[Conversion of chronic necrotizing pulmonary aspergillosis to invasive pulmonary aspergillosis, and successful treatment with fluconazole].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Aspergi | 1997 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune T | 1991 |
5 trials available for fluconazole and Chronic Disease
Article | Year |
---|---|
[Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)].
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; | 2005 |
Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Coccidioidomycosis; Fluconazole; Humans; Lung Disea | 1995 |
[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Ch | 1996 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.
Topics: Adult; Aged; Amphotericin B; Candidiasis; Child, Preschool; Chronic Disease; Female; Fluconazole; Hu | 1991 |
45 other studies available for fluconazole and Chronic Disease
Article | Year |
---|---|
New Approach to Antifungal Activity of Fluconazole Incorporated into the Porous 6-Anhydro-α-l-Galacto-β-d-Galactan Structures Modified with Nanohydroxyapatite for Chronic-Wound Treatments-In Vitro Evaluation.
Topics: Antifungal Agents; Biofilms; Chronic Disease; Durapatite; Fluconazole; Fungi; Galactans; Hydrogels; | 2021 |
Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Chronic Disease; Dose-Response Relationship, Drug | 2018 |
Two Cases of Chronic Candidiasis in Keratitis-Ichthyosis-Deafness Syndrome.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Biopsy; Candidiasis, Cutaneous; Chronic | 2018 |
Evolution of drug resistance in an antifungal-naive chronic
Topics: Alleles; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Cystic Fibrosis; Drug Resistance, | 2018 |
Treatment and prevention of paronychia using a new combination of topicals: report of 30 cases.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; A | 2015 |
Dramatic improvement of yellow nail syndrome with a combination of intralesional triamcinolone, fluconazole, and sinusitis management.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Chronic Disease; Drug Therapy, Combination; Fluconazole | 2015 |
Quality of life in patients with chronic vulvovaginal candidiasis: A before and after study on the impact of oral fluconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; | 2017 |
Management of chronic vulvovaginal candidiasis: a long term retrospective study.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disea | 2017 |
Thalidomide for steroid-dependent chronic disseminated candidiasis after stem cell transplantation: A case report.
Topics: Antifungal Agents; Bone Marrow Transplantation; Candida albicans; Candidiasis; Chronic Disease; Fluc | 2017 |
Chronic vulvovaginal candidiasis in patients using a levonorgestrel-containing intrauterine device.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Contraceptive Agents, Female; | 2018 |
Chronic meningitis by histoplasmosis: report of a child with acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Chronic Disease; Deoxycholic Acid; Dru | 2008 |
Chronic disseminated histoplasmosis with prolonged latency.
Topics: Adrenal Glands; Aged, 80 and over; Chronic Disease; Fatal Outcome; Fluconazole; Histoplasma; Histopl | 2010 |
Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Chronic Disease; Drug Resistance, Fu | 2010 |
A 37-year-old man with a chronic cough.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Chronic Disease; Coccidioidomycosis | 2012 |
[The Polish Gynecological Society Expert Committee recomendations regarding application of fluconazole in the treatment of vulvovaginal candidiasis].
Topics: Acute Disease; Administration, Topical; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Chron | 2012 |
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State | 2012 |
Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Fluconazole; Humans | 2002 |
Role of Pityrosporum ovale in guttate psoriasis.
Topics: Aged; Antifungal Agents; Biopsy, Needle; Chronic Disease; Dermatomycoses; Fluconazole; Follow-Up Stu | 2003 |
Chronic diarrhoea caused by Cryptococcus neoformans in a non-human immunodeficiency virus-infected patient.
Topics: Administration, Oral; Adult; Antifungal Agents; Chronic Disease; Cryptococcosis; Cryptococcus neofor | 2003 |
[A case of rapidly progressing pulmonary aspergillosis presenting various forms of shadow].
Topics: Aged; Aspergillosis; Aspergillus; Chronic Disease; Disease Progression; Female; Fluconazole; Humans; | 2003 |
Chronic vulvovaginal candidiasis.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Administra | 2004 |
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seroneg | 2004 |
Fluconazole nasal spray in the treatment of allergic fungal sinusitis: a pilot study.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Chronic Disease; Female; Fluconazole; Human | 2004 |
[Chronic-persistent infection of the auricle].
Topics: Animals; Antifungal Agents; Chronic Disease; Ear, External; Fluconazole; Humans; Leishmania tropica; | 2006 |
Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma.
Topics: Animals; Antifungal Agents; Asthma; Bronchoalveolar Lavage Fluid; Chronic Disease; Cryptococcosis; C | 2006 |
Oral candidiasis infections with limited clinical findings.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Chronic Disease; Female; Fluconazole; Humans; Male; Mid | 2006 |
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral | 1999 |
Cutaneous cryptococcus in an elderly woman with chronic essential dermatitis.
Topics: Antifungal Agents; Chronic Disease; Cryptococcosis; Cryptococcus neoformans; Dermatitis; Dermatomyco | 2006 |
Chronic fungal vaginitis: the value of cultures.
Topics: Candida; Candida albicans; Candidiasis, Vulvovaginal; Chronic Disease; Female; Fluconazole; Humans; | 1995 |
Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat.
Topics: Acute Disease; Animals; Candidiasis; Chronic Disease; Fluconazole; Leukocyte Count; Macrophage Colon | 1994 |
Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Chronic Disease; Endophthalmitis; Eye Infect | 1993 |
An unusual case of cryptococcal endophthalmitis.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Cryptococcosis; Cryptococcus; Endophthalmi | 1995 |
Immunological features of chronic adult paracoccidioidomycosis: report of a case treated with fluconazole.
Topics: Aged; Antifungal Agents; Chronic Disease; Fluconazole; Humans; Male; Paracoccidioides; Paracoccidioi | 1996 |
[Chronic pulmonary paracoccidioidomyosis in a Japanese Adult].
Topics: Antifungal Agents; Chronic Disease; Fluconazole; Humans; Lung Diseases, Fungal; Male; Middle Aged; P | 1996 |
[Use of Diflucan in the treatment of chronic and recurrent candidosis with involvement of the esophagus].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Child; Chronic Disease; | 1996 |
Chronic Candida albicans otitis media in children with immunodeficiency.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Chronic Disease; Diagnosis, Differential; F | 1997 |
Midbrain infarction: a rare presentation of cryptococcal meningitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Cerebral Infarction; Chronic Disease; Fluconazole; Humans; | 1999 |
Chronic Aspergillus sp. meningitis successfully treated with fluconazole. Case report.
Topics: Adult; Antibodies, Fungal; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fluconazole; H | 1999 |
[The results of treatment of chronic prostatitis on the background of anaerobic bacterial and fungal infections].
Topics: Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Bacterial Infections; Chronic Disease; | 1999 |
Miliary coccidioidomycosis in the immunocompetent.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Diagnosis, Diff | 2000 |
Chronic systemic (hepatosplenic) candidiasis in a patient with granulocytic sarcoma.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candidiasi | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Flucon | 2000 |
Chronic systemic candidiasis in acute leukemia.
Topics: Adolescent; Aged; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candidiasis; Child | 1992 |
Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis.
Topics: Acute Disease; Agranulocytosis; Amphotericin B; Animals; Candidiasis; Chronic Disease; Disease Model | 1990 |
First report of chronic meningitis caused by Trichosporon beigelii.
Topics: Adolescent; Amphotericin B; Chronic Disease; Drug Therapy, Combination; Fluconazole; Flucytosine; Hu | 1990 |